Your browser doesn't support javascript.
loading
B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis.
Antonopoulos, Ioannis; Daoussis, Dimitrios; Lalioti, Maria-Eleni; Markatseli, Theodora E; Drosos, Alexandros A; Taraviras, Stavros; Andonopoulos, Andrew P; Liossis, Stamatis-Nick C.
Afiliação
  • Antonopoulos I; Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504, Patras, Greece.
  • Daoussis D; Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504, Patras, Greece.
  • Lalioti ME; Department of Physiology, School of Medicine, University of Patras, Rion, 26504, Patras, Greece.
  • Markatseli TE; Department of Rheumatology, Ioannina University Hospital, University of Ioannina Medical School, Ioannina, Greece.
  • Drosos AA; Department of Rheumatology, Ioannina University Hospital, University of Ioannina Medical School, Ioannina, Greece.
  • Taraviras S; Department of Physiology, School of Medicine, University of Patras, Rion, 26504, Patras, Greece.
  • Andonopoulos AP; Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504, Patras, Greece.
  • Liossis SC; Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504, Patras, Greece. snliossis@med.upatras.gr.
Rheumatol Int ; 39(11): 1889-1898, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31227855

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Linfócitos T CD4-Positivos / Interleucina-4 / Rituximab / Fatores Imunológicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Linfócitos T CD4-Positivos / Interleucina-4 / Rituximab / Fatores Imunológicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article